HERVolution Therapeutics released peer-reviewed data on its engineered HERV-K immunotherapy platform, IPT-001, showing broad expression of HERV-K across 43 cancer types in 1,353 patients. The study details how a specific mutation enhances immune recognition, breaking tolerance to this viral antigen and eliciting strong immune responses in human cells and animal models. This supports IPT-001's potential as a new cancer treatment and its upcoming first-in-human trials, particularly in lung cancer. The findings also highlight HERV-K as a promising target for therapies beyond oncology, including metabolic diseases and aging-related conditions.
HERVolution Therapeutics data release offers context for health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 03:21 WIB: Out of 150 US health stocks, 103 rose and 46 fell. Notable movers include DNA at USD 13.33 (+18.28%), NUWE at USD 6.25 (+17.26%), and TDOC at USD 7.55 (+17.05%).
Fort Technology received a notification from Nasdaq on October 13, 2026, stating it failed to meet the minimum bid price requirement of $1.00 per share over the past 30 days. The company has 180 days, until April 12, 2027, to restore its share price ...
The global mobile battery market, valued at $24.9 billion in 2025, is projected to grow to $45.95 billion by 2035, driven by rising smartphone adoption, 5G rollout, and demand for longer-lasting, fast-charging batteries. Lithium-ion batteries dominat...
SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...
SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...
SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...
